NCT01909596

Brief Summary

The purpose of this is to test lateral foot orthoses with different amount of wedging to find a model that predicts the optimal lateral inclination of foot orthosis based on biomechanical or feelings measures. This study was a cross-sectional study with patients serving as their own control. The investigators recruited 24 knee osteoarthritis. Knee radiography and clinical angles measures was carried out before making orthoses, then motion analysis with an optoelectronic system was performed with each pair of foot orthoses. During motion analysis, five gait trials were carried out in each condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

July 17, 2013

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 26, 2013

Completed
Last Updated

May 16, 2024

Status Verified

May 1, 2024

Enrollment Period

1 year

First QC Date

July 17, 2013

Last Update Submit

May 13, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Knee pain

    A 20-cm visual analog scale (0-100) is used to assess pain.

    At time of device receipt

  • Knee adduction moment

    Measure of the knee adduction moment is a non invasive technic to identify change in medial knee loading, major problem in medial knee osteoarthritis.

    At time of device receipt

Secondary Outcomes (1)

  • Foot orthoses comfort

    At time of device receipt

Study Arms (4)

Knee osteoarthritis patients - No insoles

NO INTERVENTION

Without orthoses

Knee osteoarthritis patients - Customised

ACTIVE COMPARATOR

Medial arch support without lateral wedge

Device: Neutral customized foot orthoses

Knee osteoarthritis patients - Customised + 6°

ACTIVE COMPARATOR

6° lateral wedge insoles + Medial arch support

Device: 6° lateral customized foot orthoses

Knee osteoarthritis patients - Customised + 10°

ACTIVE COMPARATOR

10° lateral wedge insoles + Medial arch support

Device: 10° lateral customized foot orthoses

Interventions

Foot orthoses with arch support and without lateral inclination

Also known as: Orthoconcept Inc, Laval, Qc, Canada
Knee osteoarthritis patients - Customised

Foot orthoses with arch support above insoles with lateral inclination set at 6°

Also known as: Orthoconcept Inc, Laval, Qc, Canada
Knee osteoarthritis patients - Customised + 6°

Foot orthoses with arch support above insoles with lateral inclination set at 10°

Also known as: Orthoconcept Inc, Laval, Qc, Canada
Knee osteoarthritis patients - Customised + 10°

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptomatic medial knee osteoarthritis (OA ; Kellgren-Lawrence grade I, II or III) according to clinical and radiological criteria of the American College of Rheumatology
  • Knee pain \> 31/100 (Western Ontario and McMaster Universities Arthritis Index - WOMAC)
  • Moderately active
  • Varus knee alignment equal or superior to 2°

You may not qualify if:

  • Severe knee OA (K-L grade IV)
  • Rheumatoid arthritis or other inflammatory arthritis
  • Avascular necrosis
  • History of periarticular fracture or septic arthritis
  • Bone metabolic disease
  • Pigmented villonodular synovitis
  • Cartilaginous disease
  • Neuropathic arthropathy
  • Synovial osteochondromatosis
  • Total or partial knee arthroplasty
  • Flexion contracture of ipsi- or contra-lateral knee greater than 15°
  • Hip or ankle joint damage with mobility limitation
  • Obesity (BMI ≥ 40)
  • Intra-articular corticosteroids injection in the affected knee during the two previous months
  • Reduced mobility (Charnley class C)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pavillon de l'Éducation Physique et des Sports - Université Laval

Québec, Quebec, G1V 0A6, Canada

Location

Study Officials

  • Philippe Corbeil, PhD

    Laval University

    STUDY DIRECTOR
  • Yoann Dessery, MSc

    Laval University

    PRINCIPAL INVESTIGATOR
  • Étienne L Belzile, MD

    Laval University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2013

First Posted

July 26, 2013

Study Start

May 1, 2011

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

May 16, 2024

Record last verified: 2024-05

Locations